Management of Infants Treated for Respiratory Viral Infections: A Finnish Retrospective Register-Based Study

Sallamaria Länsisalo1, Paula Heikkilä2,3, Sauli Palmu2,4

  • 1Faculty of Medicine and Health Technology Tampere University Tampere Finland.

Health Science Reports
|October 30, 2025
PubMed

Insights

Infants with respiratory infections often received symptom-relieving medications with good results. Antibiotics were frequently used, even for viral infections, often to treat secondary bacterial infections like otitis media.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Viral respiratory tract infections are highly prevalent in children, leading to numerous healthcare visits.
  • Infants, particularly those under one year, experience the highest incidence of respiratory infections.

Purpose of the Study:

  • To analyze treatment patterns for infants with fever and respiratory symptoms at Tampere University Hospital (Tays).
  • To evaluate infant responses to various treatments administered during hospitalization.
  • To identify the specific diagnoses underlying respiratory symptoms in infants.

Main Methods:

  • Retrospective analysis of electronic patient records for infants under one year old presenting with fever and respiratory symptoms.
  • Documentation of medications, treatments, and initial responses to therapy.
  • Focus on the first instance of medication administration if repeated.

Main Results:

  • Out of 119 infant episodes, 50 (42%) required hospitalization.
  • Symptom-relieving medications like paracetamol were commonly administered with positive outcomes.
  • Antibiotics were given to 59% of infants, primarily for otitis media; bronchiolitis/bronchitis was the most frequent diagnosis (43%).

Conclusions:

  • Hospitalization was necessary for nearly half of the infants studied.
  • Analgesics and other symptom-relieving drugs were primary treatment choices, demonstrating good efficacy.
  • Antibiotic use was common, even in cases of predominantly viral infections, often addressing secondary bacterial infections.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
742
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
443
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
946
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
817